Cmbio

Cmbio is a multi-omics research partner advancing human, animal, and planetary health through microbiome science and clinical microbiomics. Bringing together Clinical Microbiomics, CosmosID, DNASense, and MS-Omics, the organization serves researchers and science-driven companies with end-to-end research services, advanced bioinformatics, and data science. Its team of more than 100 specialists works across microbiology, metabolomics, molecular biology, bioinformatics, and data science, with laboratories in the United States and Denmark and a presence in the US, EU, and APAC regions.

Cmbio’s services include shotgun and long-read metagenomics, marker-gene analysis, microbial genome sequencing and strain characterization, metabolomics, metatranscriptomics, transcriptomics, proteomics, and integrated multi-omics analysis. It also provides sampling kits, project handling, biostatistics, machine learning, and support for strain tracking and engraftment. Its work spans human health research—including gut, vaginal, oral, skin, and infant microbiomes—as well as animal, agriculture, aquaculture, wastewater, and soil studies. Cmbio combines sequencing, laboratory services, and data analysis to help clients investigate microbial communities, biological activity, and health-related outcomes.